Quantum biopharma announces update to previously announced private placement

Toronto, ontario--(newsfile corp. - august 11, 2025) - quantum biopharma ltd. (nasdaq: qntm) (cse: qntm) (fse: 0k91) ("quantum biopharma" or the "company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announces that further to its press release dated june 27, 2025, the company will be seeking shareholder approval of its non-brokered private placement of class a multiple voting shares ("mvs") for aggregate gross proceeds of up to $600 (the "offering") at its upcoming annual general and special meeting being held on september 26, 2025 (the "meeting").
QNTM Ratings Summary
QNTM Quant Ranking